Instagram is a fairly close second, Facebook a fighting third, Twitter a respectable fourth and LinkedIn a visible fifth.

Clarius Mobile Health of Vancouver, B.C., has won FDA approval to market an AI model that works with the company’s handheld point-of-care ultrasound devices to identify and measure tendons of the foot, ankle and knee.

Prenatal MRI is adept at revealing potentially damaging placental lesions affecting fetuses whose mothers were infected with COVID-19 while carrying.

The FDA has cleared U.K.-based Adaptix to market a 3D X-ray system that, according to the company, images hands, feet and elbows “at a fraction of the radiation dose and per-study cost of traditional CT.”

Shimadzu Medical Systems USA released the latest version of its Trinias angiography system at the Radiological Society of North America (RSNA) 2022 meeting to address radiation concerns and to help improve workflow.
 

Results demonstrate how implementing adjusted procedures to limit radiation exposures for children may lower cancer risks and save on health care costs.

MGMA and AHA discuss how the end of the PHE will impact healthcare stakeholders.

Signify Research shares the latest big trends in cardiovascular IT systems, including the role of EMR cardiology modules vs. third-party CVIS, structured reporting, integration into enterprise imaging and inclusion of ambulatory surgical centers.